364 results on '"Rashidi, Mohsen"'
Search Results
2. Correction: Comprehensive review of CRISPR‑based gene editing: mechanisms, challenges, and applications in cancer therapy
3. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
4. Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer
5. In vitro and silico activity of piperlongumine against azole-susceptible/resistant Aspergillus fumigatus and terbinafine-susceptible/resistant Trichophyton species
6. Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies
7. Lutein improves remyelination by reducing of neuroinflammation in C57BL/6 mouse models of multiple sclerosis
8. Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy
9. Development of a Novel Scaffold Based on Basil Seed Gum/Chitosan Hydrogel Containing Quercetin-Loaded Zein Microshphere for Bone Tissue Engineering
10. Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunities
11. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism
12. Shedding light on function of long non-coding RNAs (lncRNAs) in glioblastoma
13. Role of lncRNAs in brain tumors
14. NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies
15. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors
16. Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response
17. Evaluation of circulating innate lymphoid cells in the early pathogenesis of mouse colorectal carcinoma
18. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
19. Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
20. Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer
21. Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy
22. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery
23. Multifunctional and theranostic hydrogels for wound healing acceleration: An emphasis on diabetic-related chronic wounds
24. The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review
25. Saccharin based ionic liquid: Novel and recyclable catalyst for eco-friendly mechanosynthesis of Biginelli and Hantzcsh heterocycles under solvent-free conditions
26. Graphene oxide nanoarchitectures in cancer therapy: Drug and gene delivery, phototherapy, immunotherapy, and vaccine development
27. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation
28. STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
29. Biological and therapeutic viewpoints towards role of miR-218 in human cancers: Revisiting molecular interactions and future clinical translations
30. Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
31. Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application
32. Colon cancer transcriptome
33. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
34. Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers
35. Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response
36. HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
37. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
38. The pricing of information asymmetry based on environmental uncertainty and accounting conservatism
39. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
40. Xanthomicrol: Effective therapy for cancer treatment
41. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
42. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
43. Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects
44. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
45. Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro
46. An evaluation on potential anti-oxidant and anti-inflammatory effects of Crocin
47. Non-coding RNAs and macrophage interaction in tumor progression
48. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line
49. Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy
50. Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.